Showing 11-20 of 39 results for "".
DERM2020 Content Recap: Julie Harper, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-julie-harper-md/19844/DERM20920 Faculty Julie Harper, MD discusses what’s new in rosacea from her presentation during DERM2020.- BTL HIFEM Devices Honored by Harper's Bazaar, NewBeautyhttps://practicaldermatology.com/news/btl-hifem-devices-honored-by-harpers-bazaar-newbeauty/2459976/BTL has received two new accolades from NewBeauty and Harper's Bazaar magazines. Both EMSCULPT and BTL EMSELLA received a NewBeauty Innovation Award, as featured in the Spring issue, on stands today. EMSCULPT was also named a 2019 Harper's Bazaar Anti-Aging Award Winner. Only eleven "Innovation" h…
Treating Hormonal Acne
https://practicaldermatology.com/topics/acne-rosacea/treating-hormonal-acne/19984/Although her presentation focused on treating women with acne, Julie Harper, MD says it’s important to remember men suffer from hormonal acne too, and clascoterone cream offers a great new option. She also talks about the role of birth control and antibiotics for women, and when a workup for hyperanThe Importance of Continuing Education
https://practicaldermatology.com/series/dermatology-education-foundation/the-importance-of-continuing-education/19993/Continuing education is important for all dermatology PAs, NPs, and physicians. Julie Harper, MD says educational meetings like DERM2021 offer a great opportunity to learn about what's new and how to combine therapies to provide the best care for patients.DermWire TV: Maui Derm Highlights, Plus New and Emerging Treatments for HS and Acne
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-maui-derm-highlights-plus-new-and-emerging-treatments-for-hs-and-acne/20258/In this episode of DermWire TV, we recap the biggest news from Maui Derm 2024, including safety and efficacy studies on bimekizumab, deucravacitinib, and upadacitinib. Also from Maui Derm, Raj Chovatiya, MD, PhD, highlights new therapies to treat hidradenitis suppurativa and Julie Harper, MD, highliDermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-acneally-launches-rosacea-insights-mc2epi-collaboration/19849/Dennis Porto, MD and Riyaz Farhaad, MD have launched AcneAlly.com, an online service that allows patients access to a board certified dermatologist and a standardized approach to assessment and long-term monitoring. Julie Harper, MD discusses findings from “Beyond the visible: Rosacea and psoriasis- Review and Analysis: Triple-agent Fixed-dose Combo Tops Acne Treatmentshttps://practicaldermatology.com/news/comparative-effectiveness-moderate-severe-acne-treatments-systematic-review-and-network-meta-analysis/2462740/A topical triple-agent fixed-dose combination (FDC) was shown to be efficacious in comparison to other acne agents, according to results from a new systematic literature review and network meta-analysis looking at the comparative effectiveness of treatments for moderate-to-severe acne. The author…
- National Rosacea Society Awards 2023 Research Grantshttps://practicaldermatology.com/news/national-rosacea-society-awards-2023-research-grants/2462117/The National Rosacea Society (NRS) has announced that it will contribute funding for one new study, continue funding for two ongoing studies, as part of its grant program to advance rosacea research. "Ongoing research into the pathologic processes of rosacea has enabled ever more therapies that c…
- NEA Announces 2022 Research Grant Recipientshttps://practicaldermatology.com/news/nea-announces-2022-research-grant-recipients/2461457/The National Eczema Association (NEA) announced the recipients for its 2022 research grants. From both U.S.-based and international applications, the research projects of 13 investigators were selected, representing grants totaling nearly $730,000. 2022 marked a significant jump in NEA's investmen…
- Celebrities Come Together for EB Research Partnershiphttps://practicaldermatology.com/news/celebrities-come-together-for-eb-research-partnership/2461453/EB Research Partnership (EBRP) presented the third annual Venture Into Cures, an inspiring virtual event featuring moving stories about individuals and families living with Epidermolysis Bullosa (EB). Co-founders Eddie and Jill Vedder, along with their daughters Olivia and Harper Vedder, were joine…